1. Home
  2. JMIA vs FTRE Comparison

JMIA vs FTRE Comparison

Compare JMIA & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jumia Technologies AG each representing two

JMIA

Jumia Technologies AG each representing two

HOLD

Current Price

$7.17

Market Cap

862.0M

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$9.63

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JMIA
FTRE
Founded
2012
1996
Country
Germany
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
862.0M
829.3M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
JMIA
FTRE
Price
$7.17
$9.63
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$16.75
$14.06
AVG Volume (30 Days)
2.1M
913.0K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
$22.18
N/A
Revenue Next Year
$23.26
$3.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.00
52 Week Low
$2.13
$3.97
52 Week High
$14.72
$18.67

Technical Indicators

Market Signals
Indicator
JMIA
FTRE
Relative Strength Index (RSI) 44.86 46.21
Support Level $6.58 $9.56
Resistance Level $8.43 $10.47
Average True Range (ATR) 0.47 0.63
MACD 0.07 0.09
Stochastic Oscillator 31.64 39.04

Price Performance

Historical Comparison
JMIA
FTRE

About JMIA Jumia Technologies AG each representing two

Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace that connects sellers with consumers. The logistics services of the company enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. The company generates revenue from first-party sales, third-party sales, marketing and advertising, and the provision of other services. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: